The Relationship Between Citicoline Administration and the National Institute of Health Stroke Scale in Hemorrhagic Stroke Patients at Dr. Regional General Hospital Chasbullah Abdulmadjid Bekasi City in 2022

Abstract

Background: Hemorrhagic stroke is a focal or generalized neurological deficit that occurs suddenly within seconds or hours caused by a ruptured blood vessel. Hemorrhagic stroke can be divided into Intracerebral Hemorrhage (ICH) and Subarachnoid Hemorrhage (SAH). The prevalence of stroke in Indonesia, according to Riskesdas, in 2018 reached 10.9%; the highest cases occurred at the age of ≥55 years and were dominated by men. Treatment of hemorrhagic stroke can use citicoline as a neuroprotectant to repair brain cell membranes. One of the tools that can be used if there is a neurological deficit is the National Institute of Health Stroke Scale (NIHSS), which is useful for assessing the state of improvement of post-stroke patients. Purpose: To determine the relationship between the administration of citicoline and the NIHSS of hemorrhagic stroke patients. Methods: Descriptive analytics with a cross-sectional design using medical record data from the Regional General Hospital dr. Chasbullah Abdulmadjid Bekasi City had 95 patients based on the inclusion criteria. Results: The data from this study were processed using the Chi-Square test, which showed a significant relationship between citicoline administration and the NIHSS in hemorrhagic stroke patients with p-value = 0.017 (p <0.05). Conclusion: The administering of citicoline therapy in hemorrhagic stroke patients improved the NIHSS score. Keywords: Hemorrhagic stroke, Citicoline, NIHSS